Open access · CC-BY
via OpenAlex
Metformin Treatment Prevents Sedentariness Related Damages in Mice
Pamela Senesi, Anna Montesano, Livio Luzi, Roberto Codella, Stefano Benedini, Ileana Terruzzi
Journal of Diabetes Research · 2015 · ▲ 40 citations
Deregulated nutrient-sensing
Altered intercellular communication
Metformin
Exercise
Cell culture / in vitro
Mouse
In vitro
Abstract
Metformin (METF), historical antihyperglycemic drug, is a likely candidate for lifespan extension, treatment and prevention of sedentariness damages, insulin resistance, and obesity. Skeletal muscle is a highly adaptable tissue, capable of hypertrophy response to resistance training and of regeneration after damage. Aims of this work were to investigate METF ability to prevent sedentariness damage and to enhance skeletal muscle function. Sedentary 12-week-old C57BL/6 mice were treated with METF (250 mg/kg per day, in drinking water) for 60 days. METF role on skeletal muscle differentiation was studied in vitro using murine C2C12 myoblasts. Muscular performance evaluation revealed that METF enhanced mice physical performance (Estimated VO2max). Biochemical analyses of hepatic and muscular tissues indicated that in liver METF increased AMPK and CAMKII signaling. In contrast, METF inactivated ERKs, the principal kinases involved in hepatic stress. In skeletal muscle, METF activated AKT, key kinase in skeletal muscle mass maintenance. In in vitro studies, METF did not modify the C2C12 proliferation capacity, while it positively influenced the differentiation process and myotube maturation. In conclusion, our novel results suggest that METF has a positive action not only on the promotion of healthy aging but also on the prevention of sedentariness damages.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1155/2016/8274689
- Canonical
- link ↗
- Fetched
- 2026-11-07 MST
Cite this
APA
Senesi, P., Montesano, A., Luzi, L., Codella, R., Benedini, S., & Terruzzi, I. (2015). Metformin Treatment Prevents Sedentariness Related Damages in Mice. <em>Journal of Diabetes Research</em>. https://doi.org/10.1155/2016/8274689
Vancouver
Senesi P, Montesano A, Luzi L, Codella R, Benedini S, Terruzzi I. Metformin Treatment Prevents Sedentariness Related Damages in Mice. Journal of Diabetes Research. 2015. doi:10.1155/2016/8274689.
BibTeX
@article{pamela2015Metfor,
title = {Metformin Treatment Prevents Sedentariness Related Damages in Mice},
author = {Pamela Senesi and Anna Montesano and Livio Luzi and Roberto Codella and Stefano Benedini and Ileana Terruzzi},
journal = {Journal of Diabetes Research},
year = {2015},
doi = {10.1155/2016/8274689},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
PLoS ONE 2014
Open access · CC-BY
Metformin Protects Skeletal Muscle from Cardiotoxin Induced Degeneration
PubMed Central 2020
Preprint · CC-BY
Caenorhabditis Intervention Testing Program: the creatine analog β-guanidinopropionic acid does not extend lifespan in nematodes
JAR life 2026
Open access · OA
The exercise-gut-muscle axis in physical frailty: A narrative review.
Ankara City Hospital Bilkent 2025
Open access · US-GOV
Evaluation of the Association Between Serum Selenium Levels and Sarcopenia and Frailty in Patients Receiving Maintenance Hemodialysis
Aging and Disease 2020
Open access · CC-BY
Antidiabetic Drug Metformin Ameliorates Depressive-Like Behavior in Mice with Chronic Restraint Stress via Activation of AMP-Activated Protein Kinase
University of Utah 2019
Open access · US-GOV